New drug may be the breath of life in intensive care

A new drug to treat potentially fatal lung injuries caused by ventilators in hospital intensive care units is being developed by Flinders University researchers.

Ms Alison Elder, a PhD candidate in the Department of , and her colleagues have trialled feG, a new anti-inflammatory drug that is successful in treating and , in models of lung injury in rats.

They found the drug may be able to both prevent and effectively treat ventilator-induced lung injury.

“Ventilators are essential to keep people breathing in intensive care, but can also cause deadly lung damage by forcefully stretching the delicate tissues of the lung,” Ms Elder said.

“By significantly reducing lung damage and improving respiratory function this drug could reduce patient mortality in the ,” she said.

Stretching of the lung tissue triggers our immune system to release chemicals that cause inflammation. This can result in further tissue damage, impaired oxygen exchange and fluid accumulation in the lung, leading to death.

“The drug works in three ways: it decreases the infiltration of the inflammatory cells into the lung; it decreases their activation; and it encourages resolution of the injury within the lung,” Ms. Elder said.

Mortality rates for patients with acute increase from 24 per cent for patients 15-19 years old up to 60 per cent for patients 85 years and older, and it is also a significant financial burden for the health system.

The drug, which is based on a natural substance found in the salivary glands of rats, is currently being tested for treating asthma in Phase 1 trials by collaborators in Canada.

“Since patient safety testing has already begun in the asthma study, we are hoping to be in a position to start clinical trials here in Adelaide within the next few years.”

Provided by Flinders University

5 /5 (2 votes)
add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Stem cells faulty in Duchenne muscular dystrophy

16 hours ago

Like human patients, mice with a form of Duchenne muscular dystrophy undergo progressive muscle degeneration and accumulate connective tissue as they age. Now, researchers at the Stanford University School of Medicine have ...

Here's how the prion protein protects us

20 hours ago

The cellular prion protein (PrPC) has the ability to protect the brain's neurons. Although scientists have known about this protective physiological function for some time, they were lacking detailed knowledge ...

Regulation of maternal miRNAs in early embryos revealed

21 hours ago

The Center for RNA Research at the Institute for Basic Science (IBS) has succeeded in revealing, for the first time, the mechanism of how miRNAs, which control gene expression, are regulated in the early embryonic stage.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.